Uveitis Treatment Market Will Touch A New Level In Upcoming Year – Key Players Forecast 2022 – 2028

 



Uveitis Treatment Market, By Treatment Type (Antivirals, Corticosteroids, Monoclonal Antibodies,  Antifungal, Analgesics, Immunosuppressant, Cycloplegic Agents,  Antibiotics,), By Disease Type (Anterior Uveitis, Pan uveitis, Posterior Uveitis), By Distribution Channel (Online Pharmacies, Hospital Pharmacies, Retail Pharmacies, Drug Stores), and By Region (North America, Asia Pacific, Latin America, Europe, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 – 2027

The Global Uveitis Treatment Market is estimated to be valued at US$ XX million in XX and is expected to exhibit a CAGR of XX% during the forecast period, as highlighted in a new report published by Coherent Market Insights.

Market Overview:

The uvea is the middle layer of tissue in the wall of the eye. It comprises of the iris, the ciliary body and the choroid. When one looks at the eye in the mirror, they will see the white part of the eye and the colored part of the eye.

Competitive Landscape:

Major players included in the global uveitis treatment market are Clearside Biomedical, Inc., Allergan, Inc., Novartis AG, AbbVie Inc., Eyegate Pharmaceuticals, Inc., Valeant Pharmaceuticals International, Inc., Alimera Sciences Inc., Galapagos, EyePoint Pharmaceuticals, Inc., Tarsius Pharma and pSivida Corp.

Key Market Drivers:

High prevalence of uveitis is expected to propel growth of the global uveitis treatment over the forecast period. For instance, as per NCBI around 10-15% of total cases in blindness in United States.

The increasing prevalence of optical infections and chronic eye disorders across the globe is expected to be one of the key factors driving the growth of the market. For instance, the number of people with eye disorders was approximately 2.95 million in 2020. 

Covid-19 Impact Analysis:

The COVID-19 pandemic has impacted the market in the form of disrupted care patterns, leading to potential disease management changes across a range of therapeutic areas. The increases cases of pandemic led to shutdowns and delay in the treatment of other disorders. Which impacted the market. Research predicts that patients of uveitis can be at huge threat of contracting COVID-19 when compared with the general population, suffering a more severe course of the virus. 

Key Takeaways:

The global uveitis market is expected to exhibit a CAGR of XX% during the forecast period (2019 – 2027), owing to key players in the market aiming on R&D of new products to expand their product portfolio. For instance, in March 2020, EyePoint Pharmaceuticals, Inc. declared positive topline 36-month follow-up data from the second Phase III trial of YUTIQ 0.18 mg three-year micro-insert for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye.

Among regions North America, Asia Pacific and Europe is anticipated to witness robust growth in global uveitis treatment market due to rising prevalence of noninfectious uveitis and rising geriatric population. For instance, as per UN.gov, there are 703 million people aged 65 years or over in the world in 2019. 

Comments

Post a Comment

Popular posts from this blog

Radiodermatitis Market Production, Consumption Status and Prospects Professional Market Research Report 2028

Image
Radiodermatitis is a cutaneous reaction that occurs as a result of irradiation used to treat cancer. Radiodermatitis affects the majority of cancer patients at some point during or after their treatment with radiation. Dry papery skin, pigmentation, peeling, ski rash, and lesions are common symptoms of this illness. The rise in the prevalence of cancer and the usage of irradiation for treatment is driving the worldwide radiodermatitis forward. Furthermore, the growing geriatric population propels the radiodermatitis market forward. Radiodermatitis has become more common as a result of enhanced radiation therapy techniques due to improved quality assurance and consistency in treatment regimens across many facilities. According to the study, more than half of individuals who receive radiotherapy develop radiodermatitis at some time throughout their treatment.  Recent technological advancements and novel treatment regimens have only been successful in partly ameliorating these adverse si
Read more

CRISPR and CAS Gene Market Growing Automation in Healthcare to Benefit Growth of the Market.

Image
Clustered regularly interspaced short palindromic repeats (CRISPR ) technology is a simple yet powerful nucleic acid-targeting editing tool for genome. It allows researchers to easily alter DNA sequences and modify gene function. It has potential applications, which include correcting genetic defects, treating, and preventing the spread of diseases. The technology is faster, cheaper, and more accurate than previous techniques of editing DNA such as ZFNs (Zinc Finger Nucleases) and TALENs (Transcription Activator-Like Effector Nucleases). Researchers are focusing on its use in animal models or isolated human cells, with the aim to eventually use the technology for routinely treating diseases in humans. Furthermore, competition among the existing players has increased owing to technological developments and their potential applications. There has been an increased focus on the highly adaptable CRISPR technology. For instance, as of May 2020, Merck KGaA has received a total of 26 CRISPR p
Read more

Cancer Registry Software Market Evaluation with Focus On development & Trends 2022 – 2028

Image
  A cancer registry is a computerized database that organizes, collects, and stores data on cancer patients in order to assess cancer-specific outcomes, conditions, and drug/medical device exposure. Cancer patient registry software is a tool for storing, managing, and providing access to cancer-specific information that aids in the creation of cancer registries.   The increasing prevalence of cancer and positive government initiatives, rising pressure to enhance the quality of care and lower healthcare costs, increasing adoption of EHRs, and growing use of cancer patient registry data for post-marketing surveillance are driving growth in this Cancer Registry Software.   The availability of free cancer registry software products is critical to the growth of the global cancer registry software industry. Registry Plus is a set of free cancer registry software packages that may be used for either special or routine data collection. It includes the CRS plus central registry databas
Read more